Sezin Ozdogan Erkul
Overview
Explore the profile of Sezin Ozdogan Erkul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
102
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaldirim H, Ozkaya A, Karabas L, Alagoz C, Alkin Z, Altunay O, et al.
Beyoglu Eye J
. 2023 Jul;
8(2):73-80.
PMID: 37521880
Objectives: The aim of the study was comparison of wet-type age-related macular degeneration in phakic and pseudophakic patients in terms of anatomical and functional success based on the real-life data...
2.
Ozturk M, Ozkaya A, Karabas L, Alagoz C, Alkin Z, Artunay O, et al.
Photodiagnosis Photodyn Ther
. 2023 Jun;
42:103640.
PMID: 37263398
Background: To investigate the anatomical and visual outcomes of the patients with neovascular age-related macular degeneration (nAMD) treated with anti-vascular endothelial growth factor (anti-VEGF), according to the baseline best-corrected visual...
3.
Cakir A, Erden B, Bolukbasi S, Sever O, Erkul S, Osmanbasoglu O, et al.
Arq Bras Oftalmol
. 2020 Oct;
83(5):396-401.
PMID: 33084817
Purpose: To compare the efficacy of three initial monthly intravitreal aflibercept injections followed by pro re nata (3+PRN) dosing versus five initial monthly intravitreal aflibercept injections followed by pro re...
4.
Erden B, Bolukbasi S, Ozkaya A, Karabas L, Alagoz C, Alkin Z, et al.
Int J Ophthalmol
. 2020 Jan;
13(1):104-111.
PMID: 31956577
Aim: To compare two different anti-vascular endothelial growth factor (anti-VEGF) treatment regimens'-a priori (PRN) and PRN regimen following the loading phase-anatomical and functional results in neovascular age-related macular degeneration (nAMD)...
5.
Ozkaya A, Karabas L, Alagoz C, Alkin Z, Artunay O, Bolukbasi S, et al.
Turk J Ophthalmol
. 2018 Nov;
48(5):232-237.
PMID: 30405944
Objectives: To evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in neovascular age-related macular degeneration (nAMD) patients. Materials And Methods: Multicenter, retrospective, interventional, non-comparative study. The...
6.
Unsal E, Eltutar K, Sultan P, Erkul S, Osmanbasoglu O
Korean J Ophthalmol
. 2017 Apr;
31(2):115-122.
PMID: 28367039
Purpose: To evaluate the safety and efficacy of intravitreal dexamethasone (IVD) implants in eyes with diabetic macular edema that did not respond to previous treatment. Methods: We included 46 eyes...
7.
Ozturker Z, Eltutar K, Karini B, Erkul S, Osmanbasoglu O, Sultan P
Clin Ophthalmol
. 2016 Sep;
10:1737-42.
PMID: 27672304
Purpose: To compare optic nerve head parameters, the thicknesses of the peripapillary retinal nerve fiber layer (pRNFL), the macular retinal nerve fiber layer (mRNFL), the ganglion cell complex (GCC), and...
8.
Eltutar K, Acar F, Ozturker Z, Unsal E, Erkul S
Curr Eye Res
. 2015 Jul;
41(4):513-20.
PMID: 26125639
Purpose: To detect early structural changes of macular ganglion cell complex (GCC), peripapillary nerve fiber layer (pNFL), and optic nerve head (ONH) topography in subjects with pseudoexfoliation (PEX) using 3-D...
9.
Unsal E, Eltutar K, Zirtiloglu S, Dincer N, Erkul S, Gungel H
Clin Ophthalmol
. 2014 Apr;
8:637-42.
PMID: 24707168
Purpose: The aim of the study reported here was to assess choroidal thickness (CT) and central macular thickness (CMT) in patients with diabetic retinopathy. Materials And Methods: A total of...
10.
Erkul S, Kapran Z, Uyar O
Int Ophthalmol
. 2013 Aug;
34(1):35-40.
PMID: 23912690
To evaluate subfoveal choroidal thickness of normal eyes with the use of the enhanced depth imaging technique of optical coherence tomography (EDI-OCT) and correlation of choroidal thickness with patient age....